BenzingaApr 21, 5:15 AM ET▼ Negative
Stock fell over 11% in pre-market after announcing proposed public offering of common stock and warrants. Maintains weak trend over medium and long terms despite strong short-term trend.
Spruce Biosciences news
$47.27−0.51%
Close Sep 29, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About Spruce Biosciences
No recent articles focused on Spruce Biosciences.
Also mentions SPRB
Articles that tag SPRB but are mainly about other companies.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology